Literature DB >> 14324832

A PRELIMINARY TRIAL OF FENFLURAMINE IN GENERAL PRACTICE.

E H DUNCAN, C A HYDE, N A REGAN, B SWEETMAN.   

Abstract

Entities:  

Keywords:  APPETITE DEPRESSANTS; CLINICAL RESEARCH; DRUG THERAPY; OBESITY; PLACEBOS; TOXICOLOGIC REPORT

Mesh:

Substances:

Year:  1965        PMID: 14324832

Source DB:  PubMed          Journal:  Br J Clin Pract        ISSN: 0007-0947


× No keyword cloud information.
  8 in total

1.  Mazindol and amphetamine as inhibitors of the uptake and releasers of 3H-dopamine by rat striatal synaptosomes.

Authors:  M O Carruba; G B Picotti; F Zambotti; P Mantegazza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-05       Impact factor: 3.000

2.  Dreaming, fenfluramine, and vitamin C.

Authors:  A Mullen; C W Wilson; B P Wilson
Journal:  Br Med J       Date:  1977-01-08

3.  Effect of long-term fenfluramine treatment on drug-metabolism in rat.

Authors:  P Arvela; N T Kärki; L Nieminen; K Bjondahl; M Möttönen
Journal:  Experientia       Date:  1973-04-15

4.  Treatment of refractory obesity with fenfluramine.

Authors:  J F Munro; D A Seaton; L J Duncan
Journal:  Br Med J       Date:  1966-09-10

5.  Fenfluramine.

Authors: 
Journal:  Br Med J       Date:  1967-07-15

Review 6.  Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

7.  Effect of fenfluramine on human growth hormone release.

Authors:  W R Sulaiman; R H Johnson
Journal:  Br Med J       Date:  1973-05-12

8.  Effects of mazindol, fenfluramine and chlorimipramine on the 5-hydroxytryptamine uptake and storage mechanisms in rat brain: similarities and differences.

Authors:  M O Carruba; G B Picotti; F Zambotti; P Mantegazza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.